Tags Archives: ecmo

Perfusfind S.L.

Abstract Background:  The use of extracorporeal membrane oxygenation (ECMO) in coronavirus disease 2019 (COVID-19) for refractory respiratory failure, severe cardiac dysfunction, and bridge to lung transplantation has been steadily increasing..

Perfusfind S.L.

Abstract Accidental hypothermia (AH) in Mediterranean countries often is underestimated. AH should be suspected in patients also in moderate climates throughout all seasons. Compared with other countries, the mortality rate..

Perfusfind S.L.

Abstract Background: To assess the impact of diagnostic procedures in identifying residual lesions during extracorporeal membrane oxygenation (ECMO) on survival after pediatric cardiac surgery. Methods: Between January 2012 and December..

Perfusfind S.L.

  EuroELSO Webinar on 30 March 2021 Topic: Anticoagulation monitoring on ECMO in neonates and children: moving target - anti Xa over ACT & APTT.   Introduction, moderation & closing..

Perfusfind S.L.

Equipo de Cirugía Cardiovascular Hospital Christus Muguerza. Monterey. Nuevo León. México. -Dr Guillermo Quezada. Cirujano Cardiovascular Pediátrico. -Dr Rosemberg Albores. Anestesiólogo Cardiovascular -Dr Cesar Hernandez. Intensivista Pediátra. Moderadora: Perf Maria..

Perfusfind S.L.

Abstract Refractory cardiogenic shock (CS) often requires veno-arterial extracorporeal membrane oxygenation (VA-ECMO) to sustain end-organ perfusion. Current animal models result in heterogenous cardiac injury and frequent episodes of refractory ventricular..

Perfusfind S.L.

Patient with Covid 19 and LV failure refractory under mechanical ventilation to the treatment undergone central ECMO with inflow access right femoral vein and outflow access to the ascending aorta..

Perfusfind S.L.

Abstract Extracorporeal Membrane Oxygenation (ECMO) is commonly associated with a high blood transfusion requirement. Jehovah’s Witness patients present a particular challenge. The impossibility of transfusing blood cells and starting anticoagulation..

Perfusfind S.L.

Abstract Background: The prevalence of delirium and its association with long-term outcomes of extracorporeal membrane oxygenation (ECMO) therapy have not yet been identified. We aimed to investigate the prevalence of delirium..

Perfusfind S.L.

ABSTRACT In 1952, John Gibbon performed the first successful cardiac procedure using cardiopulmonary bypass, which turned out to be one of the most important clinical advances of that year. Cardiopulmonary..

Perfusfind S.L.

Abstract We present the case of a 13-year-old male with a complex congenital cardiac history who was supported with extracorporeal membrane oxygenation for 394 days while awaiting cardiac transplantation. The..

Perfusfind S.L.

Abstract Background: The aim of this study was to determine epidemiology and outcomes of acute kidney injury (AKI) in patients on extracorporeal membrane oxygenation (ECMO) and to assess if age modifies..

Perfusfind S.L.

Abstract Background Extracorporeal cardiopulmonary resuscitation (eCPR) is a rapidly growing treatment strategy due to increasing survival rates in selected patients. Additional left ventricular mechanical unloading, using a transfemoral micro-axial blood..

Perfusfind S.L.

Abstract Background Over the course of the COVID-19 pandemic, the care of patients with COVID-19 has changed and the use of extracorporeal membrane oxygenation (ECMO) has increased. We aimed to..

Perfusfind S.L.

Abstract Extracorporeal membrane oxygenation (ECMO) is a common treatment for cardiopulmonary failure. Although it can effectively reduce the mortality of patients with cardiopulmonary failure, it still has a high mortality..

Perfusfind S.L.

Abstract The coronavirus disease 2019 (COVID-19) pandemic began in the United States around March 2020. Because of limited access to extracorporeal membrane oxygenation (ECMO) in the authors’ region, a mobile..

Perfusfind S.L.

Lilliput 2 ECMO is the new version completing the Lilliput oxygenators' family. Equipped with a long-term usage validated polymethylpentene membrane, it guarantees optimal performance for neonatal and infant patients undergoing..

Perfusfind S.L.

Abstract Extracorporeal membrane oxygenation (ECMO) is used in critical care to manage patients with severe respiratory and cardiac failure. ECMO brings blood from a critically ill patient into contact with..

Perfusfind S.L.

Hypoxic-ischemic brain injury is the main cause of death or disability in patients resuscitated from cardiac arrest (CA). Veno-arterial extracorporeal membrane oxygenation (VA ECMO) may be used as a mechanical support for..

Perfusfind S.L.

Abstract Extracorporeal membrane oxygenation (ECMO) provides lifesaving circulatory support and gas exchange, although hematologic complications are frequent. The relationship between ECMO and severe thrombocytopenia (platelet count <50 × 109/L) remains ill-defined. We performed..

Perfusfind S.L.

Abstract Dear Editor, In the earliest phases of the pandemic, the use of extracorporeal life support in patients with severe coronavirus disease 2019 (COVID-19) was associated with disastrous outcomes. However,..

Perfusfind S.L.

Abstract Extracorporeal membrane oxygenation (ECMO) is a last resort therapy for patients with terminal respiratory failure. In the current worldwide surge of critically ill patients with novel coronavirus disease (COVID-19),..

Perfusfind S.L.

Abstract Extracorporeal membrane oxygenation is a modified form of cardiopulmonary bypass and a complex adult critical care therapy. No evidence appears to exist on sustaining relevant quality nursing standards during..

Perfusfind S.L.

A global view of ECMO during the COVID-19 pandemic Duration: 60 minutes Language: English Date: June 25, 2020    

Perfusfind S.L.

ECMO in Covid-19: Experiences & Considerations Duration: 60 minutes Language: English Date: August 7th, 2020    

Perfusfind S.L.

Abstract FOR MORE THAN a year, patients around the world have dealt with the effects of coronavirus disease 2019 (COVID-19) infection, including acute respiratory distress syndrome (ARDS). Most patients with..

Perfusfind S.L.

Abstract This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2021. Other selected articles can be found online at https:// www...

Perfusfind S.L.

Abstract EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) is a therapeutic modality used in patients with pulmonary, cardiac, or combined cardiopulmonary failure when other methods of organ support have failed. Venovenous (VV) ECMO..

Perfusfind S.L.

Abstract There is sufficient evidence to show that prone positioning improves oxygenation and respiratory mechanics and is also associated with lower mortality in patients with moderate to severe ARDS. However,..

Perfusfind S.L.

Abstract Disclaimer:  This is an updated guideline from the Extracorporeal Life Support Organization (ELSO) for the role of extracorporeal membrane oxygenation (ECMO) for patients with severe cardiopulmonary failure due to..